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used the OCP versus those who only used the HRT. BMD measure-
ments were performed at lumbar spine and hip by DEXA scan and
results expressed as percentage gain or loss in bone mass. Records
were also compared to evaluate relief from symptoms of estro-
gen deficiency - hot flushes and night sweats as reported at the
follow-up visits. The two groups were compared for confounders
such as age, body mass index, smoking, past or family history of
bone disease, age of onset of POI.
Results: BMD of lumbar spine and femur increased signif-
icantly during the treatment with oral HRT compared to OCP
(P<0.01). With oral HRT there was 0.8% increase per year at hip
and 1.18% increase per year at spine while with OCP there was
−0.18% decrease per year at hip and −0.16% decrease per year at
spine. Therewas significantly better suppression of hypoestrogenic
symptoms in the HRT group.
Conclusion: HRT appears to suppress symptoms of estrogen
deficiency and maintain BMD more consistently than OCP in
women with POI. Larger studies with prospective designs are
needed to confirm these findings.
http://dx.doi.org/10.1016/j.maturitas.2015.02.127
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Exercise has been found to have a positive effect on the health
and well-being of postmenopausal women. The aim of this pilot
study was to determine whether an eight-week exercise and
lifestyle education intervention had an effect on the health status
and QoL of postmenopausal women living in North Queensland.
This is the first data from an ongoing project.
Participants took part in an eight-week group-based exercise
intervention of three sessions per week incorporating aerobic and
resistance training in a circuit style format and were given infor-
mational handouts on various lifestyle topics for postmenopausal
women.
Pre and post-test measurements were taken and included
peripheral bone density, resting heart rate and blood pressure,
blood lipids and cholesterol, anthropometric measures, upper
and lower body muscular strength, cardiorespiratory fitness,
menopausal QoL and exercise self-efficacy. At the completion of
the intervention, participants were invited to take part in a focus
group to explore their experiences of the program.
Fifteen sedentary postmenopausal women volunteered to take
part, of which eleven participants completed 90% of the interven-
tion. Participants improved in waist girth (p=0.00), cholesterol
(p=0.00), upper body strength (p=0.00), lower body strength
(p=0.05), psychosocial (p=0.01) and physical (p=0.03) domains
of QoL. Participants enjoyed the shared identity and social
interaction of the group-based exercise. They also enjoyed feel-
ing stronger and being able to perform daily activities more
easily.
Findings from this pilot study demonstrate that an eight-
week group-based exercise intervention is sufficient to achieve
improvements in some health status and QoL outcomes for post-
menopausal women, although a longer duration may be required.
However, participants found the exercise intervention to be a
positive experience, providing the motivation needed for future
exercise participation.
http://dx.doi.org/10.1016/j.maturitas.2015.02.128
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Introduction: The first ‘Women’s Health Initiative’ (WHI)
randomised controlled trial assessed use of continuous com-
bined menopausal hormone therapy (cc-MHT). It was prematurely
stopped because of an increased invasive breast cancer (BC), coro-
nary heart disease (CHD), stroke and pulmonary embolism risk.
Consequently, scientific societies recommended use of MHT at the
lowest effective dose for the shortest duration. As a result, a sharp
decline in MHT use occurred worldwide.
Aim: To report in a uniform way the change in MHT use in Euro-
pean countries. To evaluate whether the variability of the MHT
changes were related to some medical indicators.
Materials and methods: IMS Health provided MHT sales data
for the years 2002 till 2010 for 17 countries. We tested several
hypotheses to explain the heterogeneity of MHT use changes.
Results and discussion: In 2002, the estimated MHT rate in
women 45–69 years old varied considerably between countries
ranging from less than 5% to more than 25%. In all countries a pro-
founddecrease occurredbetween2002and2010, ranging from50%
to77%.By theendof2010, theMHTuptakewas lower than10% inall
countries except in Finland. MHT use change was not correlated to
MHTuse and prevailing BC incidence at baseline, nor to the number
of gynaecologists per 100,000 women or to the level of information
about MHT.
Conclusions: The global MHT use experienced a sharp decrease
in all the analysed countries, although some variability exists. The
decrease was unrelated to assessed parameters.
http://dx.doi.org/10.1016/j.maturitas.2015.02.129
